Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,903.50    -9.50 (-0.50%)
Bid:
1,904.00
Ask:
1,905.00
Spread: 1.00 (0.053%)
Market Cap: £76.34b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

LONDON BRIEFING: Elementis says CEO Waterman to step down next year
18 Nov 2024

LONDON BRIEFING: Elementis says CEO Waterman to step down next year

(Alliance News) - The FTSE 100 was called to open lower on Monday, ahead of trade balance data from the eurozone and comments from Bank of England Gov...

LONDON MARKET CLOSE: Stocks struggle as Powell signals slower Fed cuts
15 Nov 2024

LONDON MARKET CLOSE: Stocks struggle as Powell signals slower Fed cuts

(Alliance News) - Stock prices in London closed lower, while equities in New York opened in the red after Federal Reserve Chair Jerome Powell dashed r...

London close: Stocks end turbulent week in the red
15 Nov 2024

London close: Stocks end turbulent week in the red

(Sharecast News) - London stocks ended Friday in negative territory, weighed down by losses in pharmaceutical shares and a surprise slowdown in UK eco...

LONDON MARKET MIDDAY: Stocks turn greener despite "gloomy" government
15 Nov 2024

LONDON MARKET MIDDAY: Stocks turn greener despite "gloomy" government

(Alliance News) - Stock prices in London were mostly higher at midday on Friday, despite disappointing data including weaker-than-expected gross domes...

GSK hails survival results in blood cancer patients with Blenrep
14 Nov 2024

GSK hails survival results in blood cancer patients with Blenrep

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myelo...

GSK's Blenrep shows strong survival benefit in myeloma study
14 Nov 2024

GSK's Blenrep shows strong survival benefit in myeloma study

(Sharecast News) - GSK reported positive results from its phase three 'DREAMM-7' trial on Thursday, highlighting a significant overall survival benefi...

LONDON MARKET CLOSE: Stocks slip and pound falls but dollar rides high
12 Nov 2024

LONDON MARKET CLOSE: Stocks slip and pound falls but dollar rides high

(Alliance News) - London's FTSE 100 resumed its downward path on Tuesday, as a mixed bag of earnings, political uncertainty, and stronger-than-expecte...

LONDON BROKER RATINGS: Jefferies cuts Big Yellow, Shore cuts ITV
12 Nov 2024

LONDON BROKER RATINGS: Jefferies cuts Big Yellow, Shore cuts ITV

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: